Baseline Clinical and Laboratory Features Predict Risk of Developing Symptomatic Thromboembolism (STE) During Antileukemic Therapy in Children with De Novo Acute Lymphoblastic Leukemia (ALL) Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

publication date

  • November 1, 2016